Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 8Breast 3Other 2

Conditions

Sexuality 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Breast Neoplasms 1

Interventions

Exercise 28Metformin 24Surveys and Questionnaires 19Radiotherapy 14Methods 14Early Intervention, Educational 13Counseling 13Educational Status 12naloxegol 10Standard of Care 10Tirzepatide 9Nutrition Assessment 9Diet Therapy 9Cisplatin 9Resistance Training 8Psychiatric Rehabilitation 8Diet 8Therapeutics 7Interviews as Topic 7alvimopan 6Liraglutide 6Fibroblast Growth Factor 7 6Caloric Restriction 6semaglutide 5Radiation 5Low-Level Light Therapy 5Injections 5Exenatide 5Diet, Mediterranean 5Dexamethasone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Testosterone Propionate × Other × Clear all
NCT00612742 2021-10-29

BLOOM

BioSante Pharmaceuticals

Phase 3 Completed
3,656 enrolled
BreastOther

Breast Neoplasms, Sexual Dysfunctions, Psychological

NCT00075855 2016-07-13

Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors

Alliance for Clinical Trials in Oncology

Phase 3 Completed
150 enrolled
Other

Sexual Dysfunction, Physiological, Sexuality

Data powered by HemOnc (CC BY 4.0) Colophon âš¡